pilocarpine has been researched along with Angiosarcoma in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, S | 1 |
| Tyler, AB | 1 |
| Phillips, S | 1 |
| Burnet, NG | 1 |
1 other study available for pilocarpine and Angiosarcoma
| Article | Year |
|---|---|
Oral pilocarpine improves radiotherapy-induced dry eyes.
Topics: Aged; Eye; Eye Diseases; Hemangiosarcoma; Humans; Keratitis; Male; Parasympathomimetics; Pilocarpine | 1997 |